Litigation

Walgreen Co. et al v. Allergan, Inc

Date Filed: May 16, 2018
Status: Pending
District Court: Eastern District of New York – 1:18-cv-02907
Nature of Suit: Generic Competition Block or Delay|Antitrust
Defendant Type: Pharma
Plaintiff Type: Private
Court Document: https://www.bloomberglaw.com/document/X1Q6O02E0J82?imagename=1-1.pdf

Four drug retailers, including Walgreens and Albertsons, filed an antitrust suit alleging that Allergan devised and carried out a multifaceted and anticompetitive scheme to maintain a monopoly and prevent would-be generic competitors from competing with its dry eye drug Restasis.


Associated Legislation:

No items found